Trials / Conditions / B-Cell Non-Hodgkin Lymphoma-Refractory
B-Cell Non-Hodgkin Lymphoma-Refractory
3 registered clinical trials studyying B-Cell Non-Hodgkin Lymphoma-Refractory — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL NCT06618313 | Beijing GoBroad Hospital | N/A |
| Recruiting | Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma NCT06395870 | Tianjin Medical University Cancer Institute and Hospital | Phase 1 |
| Recruiting | CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma NCT06209619 | Nathan Denlinger | Phase 1 |